Spots Global Cancer Trial Database for leuprolide acetate
Every month we try and update this database with for leuprolide acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | NCT00003645 | Prostate Cancer | Flutamide Leuprolide Acet... | - | M.D. Anderson Cancer Center | |
| Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | NCT01120236 | Prostate Adenoc... Recurrent Prost... Stage IV Prosta... | Bicalutamide Cixutumumab Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Leuprolide to Treat Prostate Cancer | NCT00626431 | Prostate Cancer | Leuprolide acet... Leuprolide acet... | 18 Years - | Abbott | |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | NCT01120236 | Prostate Adenoc... Recurrent Prost... Stage IV Prosta... | Bicalutamide Cixutumumab Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer | NCT00454571 | Recurrent Prost... | pazopanib hydro... leuprolide acet... goserelin aceta... | 18 Years - | National Cancer Institute (NCI) | |
| Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS) | NCT00805935 | Polycystic Ovar... Infertility | Menotropin Progesterone va... Follitropin bet... Progesterone in... leuprolide acet... | 18 Years - 42 Years | Ferring Pharmaceuticals | |
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases | NCT00081159 | Metastatic Canc... Prostate Cancer | Doxorubicin hyd... Goserelin aceta... Leuprolide acet... Zoledronic acid orchiectomy strontium chlor... | - | M.D. Anderson Cancer Center | |
| Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection | NCT04094467 | Polycystic Ovar... | Cetrorelix Leuprolide Acet... | 20 Years - 35 Years | Assiut University | |
| Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome | NCT00004311 | Acanthosis Nigr... Polycystic Ovar... | leuprolide acet... spironolactone | 0 Years - | Office of Rare Diseases (ORD) | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT00244920 | Prostate Cancer | bicalutamide leuprolide acet... squalamine lact... adjuvant therap... antiandrogen th... antiangiogenesi... conventional su... neoadjuvant the... releasing hormo... | 18 Years - | OHSU Knight Cancer Institute | |
| Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer | NCT01023061 | Adenocarcinoma ... Stage II Prosta... Stage III Prost... Stage IV Prosta... | abiraterone ace... prednisone leuprolide acet... laboratory biom... external beam r... goserelin aceta... | 18 Years - | University of Washington | |
| Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | NCT00128531 | Prostate Cancer | leuprolide acet... | 18 Years - | GP-Pharm | |
| Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas | NCT02361905 | Fibroid | ulipristal acet... Leuprolide acet... | 18 Years - 55 Years | University Magna Graecia | |
| A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | NCT00220194 | Cancer of Prost... | leuprolide acet... | 18 Years - | San Bernardino Urological Associates Medical Group Inc | |
| A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC | NCT02592746 | Metastatic Brea... | Palbociclib Exemestane Leuprolide Acet... Capecitabine | 19 Years - | Samsung Medical Center | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer | NCT00170157 | Prostate Adenoc... Prostate Carcin... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Bicalutamide Flutamide Goserelin Aceta... Ipilimumab Leuprolide Acet... Pharmacological... | 18 Years - | Mayo Clinic | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00026377 | Prostate Cancer | bicalutamide flutamide goserelin aceta... leuprolide acet... SU5416 radiation thera... | - | University of Chicago | |
| Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | NCT00651326 | Prostate Cancer | bicalutamide buserelin flutamide goserelin leuprolide acet... neoadjuvant the... quality-of-life... radiation thera... Docetaxel | 18 Years - | Canadian Cancer Trials Group | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | NCT01786265 | Prostate Adenoc... Recurrent Prost... | Abiraterone Ace... Bicalutamide Degarelix Flutamide Goserelin Aceta... Leuprolide Acet... Nilutamide Prednisone | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | NCT02212197 | Prostate Cancer | leuprolide acet... leuprolide acet... | 40 Years - 85 Years | Camurus AB | |
| Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer | NCT02168062 | Prostate Adenoc... | Behavioral Diet... Counseling Educational Int... Exercise Interv... Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Quality-of-Life... Triptorelin Pam... | - | University of California, San Francisco | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | NCT03029533 | Prostate Cancer | Leuprolide Acet... Leuprolide Acet... | 19 Years - 80 Years | Daewoong Pharmaceutical Co. LTD. | |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | NCT05212857 | Prostate Cancer | Leuprolide acet... Goserelin aceta... Triptorelin ace... Degarelix aceta... Abiraterone ace... Apalutamide Enzalutamide Local treatment... Radiotherapy fo... Radiotherapy fo... | 18 Years - 80 Years | Fudan University | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | NCT04666129 | Metastatic Cast... Metastatic Cast... Non-Metastatic ... | Relugolix Abiraterone Prednisone Methylprednisol... Apalutamide Docetaxel | 18 Years - | Sumitomo Pharma Switzerland GmbH | |
| Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer | NCT00002889 | Prostate Cancer | flutamide goserelin leuprolide acet... low-LET photon ... | 30 Years - | Alliance for Clinical Trials in Oncology | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | NCT02058706 | Adenocarcinoma ... Recurrent Prost... Stage IV Prosta... | enzalutamide bicalutamide orchiectomy leuprolide acet... goserelin aceta... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | NCT02268175 | Prostate Adenoc... Prostate Cancer High Risk Prost... | Enzalutamide Abiraterone Ace... Prednisone Leuprolide Acet... | 18 Years - | Dana-Farber Cancer Institute | |
| A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer | NCT03085095 | Prostate Cancer | Relugolix Leuprolide Acet... | 18 Years - | Myovant Sciences GmbH | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | NCT02268175 | Prostate Adenoc... Prostate Cancer High Risk Prost... | Enzalutamide Abiraterone Ace... Prednisone Leuprolide Acet... | 18 Years - | Dana-Farber Cancer Institute | |
| Neoadjuvant Ipilimumab in Prostate Cancer | NCT01194271 | Prostate Cancer | Leuprolide Acet... Ipilimumab Radical Prostat... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy | NCT03043807 | Prostate Cancer | Leuprolide Acet... Docetaxel Bicalutamide Radiation Abiraterone Ace... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer | NCT03085095 | Prostate Cancer | Relugolix Leuprolide Acet... | 18 Years - | Myovant Sciences GmbH | |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | NCT00002582 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... oophorectomy radiation thera... | - | National Cancer Institute (NCI) | |
| Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | NCT00225420 | Prostate Cancer | docetaxel leuprolide acet... radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate | NCT05605964 | Prostate Cancer | Relugolix Leuprolide Acet... | 18 Years - | Sumitomo Pharma Switzerland GmbH | |
| Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer | NCT01163084 | Prostate Adenoc... Stage IIA Prost... Stage IIB Prost... | Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | NCT00003653 | Prostate Cancer | bicalutamide buserelin cyproterone ace... flutamide goserelin leuprolide acet... nilutamide | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study | NCT00452556 | Prostatic Neopl... | Docetaxel Leuprolide Acet... Intensity-Modul... Intensity-Modul... | - | Nova Scotia Cancer Centre | |
| Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | NCT02268175 | Prostate Adenoc... Prostate Cancer High Risk Prost... | Enzalutamide Abiraterone Ace... Prednisone Leuprolide Acet... | 18 Years - | Dana-Farber Cancer Institute | |
| Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound | NCT02736435 | Uterine Leiomyo... | Magnetic Resona... leuprolide acet... | 18 Years - 50 Years | Thunder Bay Regional Health Research Institute | |
| Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients | NCT00630799 | Prostate Cancer | leuprolide acet... | 18 Years - | GP-Pharm | |
| A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC | NCT02592746 | Metastatic Brea... | Palbociclib Exemestane Leuprolide Acet... Capecitabine | 19 Years - | Samsung Medical Center | |
| Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer | NCT00512668 | Adenocarcinoma ... Recurrent Prost... | leuprolide acet... goserelin aceta... bicalutamide nilutamide flutamide temsirolimus laboratory biom... | - | National Cancer Institute (NCI) | |
| Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | NCT04666129 | Metastatic Cast... Metastatic Cast... Non-Metastatic ... | Relugolix Abiraterone Prednisone Methylprednisol... Apalutamide Docetaxel | 18 Years - | Sumitomo Pharma Switzerland GmbH | |
| Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS) | NCT00805935 | Polycystic Ovar... Infertility | Menotropin Progesterone va... Follitropin bet... Progesterone in... leuprolide acet... | 18 Years - 42 Years | Ferring Pharmaceuticals | |
| PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial | NCT00380406 | Fertility Prese... Cancer | Leuprolide acet... | 18 Years - 38 Years | Ottawa Hospital Research Institute | |
| Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer | NCT06305598 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Biopsy Bone Scan Computed Tomogr... Leuprolide Acet... Magnetic Resona... Survey Administ... Testosterone Cy... | 18 Years - | Roswell Park Cancer Institute | |
| Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer | NCT02770391 | Prostate Cancer | Leuprolide acet... Apalutamide Radical prostat... | 18 Years - | Case Comprehensive Cancer Center | |
| Post-operative or Early Salvage XRT and ADT for High Risk PCa | NCT00949962 | Prostate Cancer | antiandrogen th... leuprolide acet... 3-dimensional c... | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer | NCT03951831 | Prostate Cancer... | REGN2810 Degarelix Leuprolide Acet... Docetaxel | 18 Years - 99 Years | Columbia University | |
| A Study of Definitive Therapy to Treat Prostate Cancer | NCT02716974 | Prostate Cancer | Leuprolide Acet... Bicalutamide Docetaxel Prostatectomy Radiation | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | NCT02212197 | Prostate Cancer | leuprolide acet... leuprolide acet... | 40 Years - 85 Years | Camurus AB | |
| Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer | NCT00003124 | Prostate Cancer | flutamide leuprolide acet... radiation thera... | - | National Cancer Institute (NCI) | |
| Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection | NCT04094467 | Polycystic Ovar... | Cetrorelix Leuprolide Acet... | 20 Years - 35 Years | Assiut University | |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | NCT00003517 | Adenocarcinoma ... Stage III Prost... Stage IV Prosta... Recurrent Prost... | antineoplaston ... antineoplaston ... bicalutamide flutamide leuprolide acet... alternative pro... antiandrogen th... biological ther... biologically ba... cancer preventi... complementary a... differentiation... endocrine thera... hormone therapy | 18 Years - | National Cancer Institute (NCI) | |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer | NCT00498901 | Breast Cancer | goserelin letrozole leuprolide acet... conventional su... | 18 Years - | University of Washington | |
| Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | NCT00002881 | Prostate Cancer | flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy | 18 Years - | National Cancer Institute (NCI) | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | NCT00003394 | Prostate Cancer | carboplatin endocrine-modul... estramustine ph... goserelin aceta... leuprolide acet... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | NCT04734730 | Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib | 18 Years - | City of Hope Medical Center | |
| Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma | NCT06348264 | Salivary Gland ... | Rezvilutamide Leuprolide Acet... | 18 Years - | Peking University First Hospital | |
| Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00544830 | PSA Level Great... Stage IV Prosta... | Bicalutamide Goserelin Aceta... Intensity-Modul... Laboratory Biom... Leuprolide Acet... | 18 Years - | City of Hope Medical Center | |
| Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study | NCT04585932 | Biochemically R... Metastatic Pros... Oligometastatic... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Apalutamide Degarelix Leuprolide Acet... Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer | NCT00498901 | Breast Cancer | goserelin letrozole leuprolide acet... conventional su... | 18 Years - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
